New hyaluronan compounds, useful for preparing viscoelastic compositions and in medical, medical implants, tissue engineering, biotechnology or cosmetics applications

摘要

Hyaluronan compounds (Q) are new. Hyaluronan compounds of formula (Q) are new. R : OH, OZ, NH2NHC(O)(CH2)pC(O)-NH-NH-, or R1aNHNHC(O)(CH 2)pC(O)NHNH-; n : 40-7500, preferably 200-4000; i : 1-n; Z : monovalent ions, such as Na + or K +, or Mg 2+; p : 1-20, preferably 1-5; R1a : (1-4)-alpha-L- glucuronate of formula (A), delta -(1-4)-alpha-L- glucuronate of formula (A1), (1-4)-beta -D- glucuronate of formula (B), delta -(1-4)-beta -D- glucuronate of formula (B1), (1-4)-alpha-D-galacturonan of formula (C), delta -(1-4)-alpha-D-galacturonan of formula (C1), poly-alpha-L-glucopyranosyluronic acid and beta -D-mannopyranosyluronic acid of formula (D), delta -poly-alpha-L-glucopyranosyl uronic acid and beta -D-mannopyranosyluronic acid of formula (D1) or (D2); and m, m1, q, q1, r, r1, s, s1 : 1-150, preferably 3-30. Independent claims are included for: (1) the preparation of (Q); and (2) a composition comprising (Q) or a mixture of (Q), optionally in the presence of divalent ions other than magnesium (Mg 2+). [Image] [Image] [Image] [Image].